title: Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways.
abstract: We show here that the neurotrophin nerve growth factor (NGF), which has been shown to be a mitogen for breast cancer cells, also stimulates cell survival through a distinct signaling pathway. Breast cancer cell lines (MCF-7, T47-D, BT-20, and MDA-MB-231) were found to express both types of NGF receptors: p140(trkA) and p75(NTR). The two other tyrosine kinase receptors for neurotrophins, TrkB and TrkC, were not expressed. The mitogenic effect of NGF on breast cancer cells required the tyrosine kinase activity of p140(trkA) as well as the mitogen-activated protein kinase (MAPK) cascade, but was independent of p75(NTR). In contrast, the anti-apoptotic effect of NGF (studied using the ceramide analogue C2) required p75(NTR) as well as the activation of the transcription factor NF-kB, but neither p140(trkA) nor MAPK was necessary. Other neurotrophins (BDNF, NT-3, NT-4/5) also induced cell survival, although not proliferation, emphasizing the importance of p75(NTR) in NGF-mediated survival. Both the pharmacological NF-kappaB inhibitor SN50, and cell transfection with IkBm, resulted in a diminution of NGF anti-apoptotic effect. These data show that two distinct signaling pathways are required for NGF activity and confirm the roles played by p75(NTR) and NF-kappaB in the activation of the survival pathway in breast cancer cells.
authors.affiliation: Equipe Facteurs de Croissance, UPRES EA-1033 Biologie du Développement, Université des Sciences et Technologies de Lille, 59655 Villeneuve d' ASCQ France.
authors.forename: S
authors.initials: S
authors.lastname: Descamps
authors.forename: R A
authors.initials: RA
authors.lastname: Toillon
authors.forename: E
authors.initials: E
authors.lastname: Adriaenssens
authors.forename: V
authors.initials: V
authors.lastname: Pawlowski
authors.forename: S M
authors.initials: SM
authors.lastname: Cool
authors.forename: V
authors.initials: V
authors.lastname: Nurcombe
authors.forename: X
authors.initials: X
authors.lastname: Le Bourhis
authors.forename: B
authors.initials: B
authors.lastname: Boilly
authors.forename: J P
authors.initials: JP
authors.lastname: Peyrat
authors.forename: H
authors.initials: H
authors.lastname: Hondermarck
mesh_terms: D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D005260:Female; D006801:Humans; D016328:NF-kappa B / Q000378:metabolism; D020932:Nerve Growth Factor / Q000494:pharmacology*; D020800:Receptor, Nerve Growth Factor / Q000378:metabolism; D020917:Receptor, trkA / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D014407:Tumor Cells, Cultured
chemical_list: D016328:NF-kappa B; D020800:Receptor, Nerve Growth Factor; D020932:Nerve Growth Factor; D020917:Receptor, trkA